Cat.#: ACPP-1294
| Despition | DCC Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1676 | Human RLBP1 Protein (AC1676) | 5 µg | inquiry |
| ACPP-1113 | Native Porcine GFAP Protein (AC1113) | 25 µl | inquiry |
| ACPP-1648 | Human RAMP1 Protein (AC1648) | 2 µg | inquiry |
| ACPP-1844 | Human GCLM Protein (AC1844) | 5 µg | inquiry |
| ACPP-1107 | Recombinant Human Syndecan-1 Protein (Fc Chimera 6xHis Tag) (AC1107) | 50 µg | inquiry |
| ACPP-1313 | Norepinephrine Transporter Blocking Peptide (AC1313) | 250 µg | inquiry |
| ACPP-1767 | Human YIF1B Protein (AC1767) | 5 µg | inquiry |
| ACPP-1243 | ELOVL4 Blocking Peptide (AC1243) | 250 µg | inquiry |
| ACPP-1204 | P2Y1 Blocking Peptide (AC1204) | 250 µg | inquiry |
| ACPP-1752 | Human ASPA Protein (AC1752) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.